Model for End-Stage Liver Disease Including Na, Age, and Sex Is Powerful Predictor of Survival in COVID-19 Patients on Extracorporeal Membrane Oxygenation
Authors:
- Freya Sophie JenkinsFJFreya Sophie Jenkins
- Mohammed MorjanMMMohammed Morjan
- Jan-Philipp MinolJMJan-Philipp Minol
- Esma YilmazEYEsma Yilmaz
- Ismail DalyanogluIDIsmail Dalyanoglu
- Moritz Benjamin ImmohrMoritz Benjamin Immohr
- Bernhard KorbmacherBKBernhard Korbmacher
- Udo BoekenUBUdo Boeken
- Artur LichtenbergALArtur Lichtenberg
- Hannan DalyanogluHDHannan Dalyanoglu
Open Access
- 4 September 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1954
Abstract
Aim: Extracorporeal membrane oxygenation (ECMO) is resource-intensive, is associated with significant morbidity and mortality, and requires careful patient selection. This study examined whether the model for end-stage liver disease (MELD) score is a suitable predictor of in-hospital mortality in patients with COVID-19. Materials and Methods: We retrospectively assessed patients with COVID-19 on ECMO at our institution from March 2020 to May 2021. MELD scoring was performed using laboratory values recorded prior to ECMO initiation. A multiple logistic regression model was established. Results: A total of 66 patients with COVID-19 on ECMO were included (median age of 58.5 years; 83.3% male). The in-hospital mortality was 74.2%. In relation to mortality, patients with MELD Na scores >13.8 showed 6.5-fold higher odds, patients aged >53.5 years showed 18.4-fold higher odds, and male patients showed 15.9-fold higher odds. The predictive power of a model combining the MELD Na with age and sex was significant (AUC = 0.883, p < 0.001). The findings in the COVID-19 patients were not generalizable to a group of non-COVID-19 patients on ECMO. Conclusions: A model combining the MELD Na, age, and sex has high predictive power for in-hospital mortality in patients with COVID-19 on ECMO, and it may be clinically useful for guiding patient selection in critically ill COVID-19 patients both now and in the future, should the virus widely re-emerge.Keywords
This publication has 27 references indexed in Scilit:
- In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational studyThe Lancet Respiratory Medicine, 2022
- MELD Score Predicts Outcomes in Patients Undergoing Venovenous Extracorporeal Membrane OxygenationASAIO Journal, 2020
- Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseasesThe Lancet Respiratory Medicine, 2020
- Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, ChinaASAIO Journal, 2020
- Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2018
- Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral centerIntensive Care Medicine, 2013
- The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndromeIntensive Care Medicine, 2013
- Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet scoreIntensive Care Medicine, 2012
- MELD-XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapyLiver Transplantation, 2006
- A model to predict survival in patients with end-stage liver diseaseGastroenterology, 2001